Background
Small for gestational age (SGA) babies (typically defined as birthweight below the 10
th centile according to gestational age [
1,
2]) are not only at increased risk of neonatal morbidity and mortality, but are also at increased risk of rapid postnatal weight gain, later obesity and diseases in adulthood such as type 2 diabetes, hypertension and ischemic heart disease [
3‐
7] which are major causes of adult morbidity and mortality worldwide. Although the cause of this association is unknown, several hypotheses have been proposed. The fetal insulin hypothesis [
8] proposes that common genes inherited by the fetus affect both birth size and predisposition to adult diseases. In contrast, the Barker hypothesis [
4,
5,
9‐
11] suggests the association to be the result of fetal programming - permanent changes in physiology and metabolism in response to adverse maternal uterine environment in pregnancy that result in increased metabolic disease risk in adulthood. The increased risk of adult metabolic diseases in those who are born small at birth is further amplified by an accelerated pattern of growth during childhood. The thrifty phenotype hypothesis explains this phenomenon by suggesting that the fetal nutrient conserving adaptations in response to intrauterine under nutrition is overwhelmed by nutrient abundance post-natally and manifests in adult metabolic diseases [
9]. Singhal and Lucas [
12] propose that it is not low birth weight per se, but this rapid postnatal growth that is responsible for the increased risk for disease in later life.
Environmental risk factors for SGA are well established and include smoking, low pregnancy weight, maternal short stature, maternal diet, ethnic origin of mother and hypertension [
13]. These risk factors have been studied and confirmed in the Auckland Birthweight Collaborative (ABC) study [
14,
15]. However, in a large proportion of SGA, no underlying cause is evident, and these individuals may have a larger genetic contribution. The existence of such genetic factors is supported by the observation that SGA births tend to cluster in families and to recur in successive generations [
16,
17]. However, genetic association publications for SGA to date have been rare and inconsistent. Infante-Rivard
et al., 2007 [
18] provides a summary overview of genetic association studies for SGA. In brief, only the thrombophilia pathway including genetic variants in
MTHFR, FV, and
FII [
19,
20], and xenobiotic-metabolizing pathways with variants in
CYP1A1, GSTT and
GSTM [
21,
22] have been studied with any frequency. Other pathways that have been studied with less frequency include the vascular dysfunction or atherosclerosis pathway with variants in
APOE, PON and
ACE [
23‐
25] and the insulin resistance pathway with variants in
IGF-1 [
26]. However, none of these pathways have shown robust associations with susceptibility to adult diseases with which SGA has been linked.
As children born SGA often become obese in later life and/or develop type 2 diabetes we tested the association between SGA and polymorphisms in genes that have previously been associated with obesity and/or type 2 diabetes under the hypothesis that a common genetic denominator might predispose to both SGA and obesity and/or type 2 diabetes. The hypothesis was tested in subjects from the Auckland Birthweight Collaborative (ABC) study. Since we began this study there have been several publications examining the relationship between type 2 diabetes susceptibility genes and birthweight (these studies are described in the discussion), however we have included both obesity and type 2 diabetes susceptibility genes and we have focused on SGA status.
Results
We do not have genotypic data for 10 SNPs: rs1387153 (MTNR1B), rs6020339 (CTNNBL1), rs2388399 (PFKP), rs477181 (MC4R), rs3820152 (ADIPOR1), rs7561317 (TMEM18), rs7647305 (ETV5 - DGKG), rs2844479 (NCR3 - AIF1), rs8050136 (FTO) and rs10487818 (NAMPT). These SNPs either could not be multiplexed into our sequenom assays, failed or did not pass our quality control measure for inclusion in the analysis. The remaining 54 SNPs produced genotypic data for analysis. Each of these SNPs had a genotyping call rate greater than 90% and the genotyping calls did not differ significantly from HWE criteria.
Nine SNPs were significant at the 10% level in the univariable analysis at either the genotypic or allelic level and each of these SNPs was then taken forward to multivariable analysis (see tables
2 and
3 for results).
Table 2
Univariable and multivariable associations of obesity and diabetes SNPs with small for gestational age at term (allelic and genotypic) data
FTO | rs9939609 | AT | A | A | A (obesity) | 33.8 | 11.4 |
0.03
| 0.42 | 1.11 | 0.86-1.43 | 0.40 | 0.63 | 1.07 | 0.80-1.44 |
JAZF1 | rs864745 | AG | G | G | A (diabetes) | 48.3 | 26.7 | 0.09 | 0.64 | 1.06 | 0.83-1.36 | 0.26 | 0.98 | 1 | 0.75-1.32 |
KCNJ11 | rs5219 | CT | T | T | T (diabetes) | 33.7 | 12.3 |
0.02
|
0.03
|
1.32
|
1.03-1.70
| 0.061 |
0.03
|
1.36
|
1.02-1.82
|
LPL | rs3200218 | GA | G | A | A (obesity) | 26.3 | 5.5 | 0.20 | 0.06 | 0.76 | 0.56-1.02 | 0.21 | 0.09 | 0.74 | 0.53-1.04 |
PFKP | rs6602024 | GA | A | G | A (obesity) | 12.0 | 0 | 0.08 | 0.13 | 0.73 | 0.49-1.10 |
0.03
| 0.06 | 0.64 | 0.40-1.02 |
PTER | rs10508503 | CT | T | C | C (obesity) | 9.8 | 0.5 |
0.04
| 0.06 | 0.64 | 0.41-1.02 | 0.07 |
0.04
|
0.58
|
0.34-0.98
|
SEC16B | rs10913469 | TC | C | T | C (obesity) | 18.0 | 1.6 |
0.05
| 0.82 | 0.96 | 0.70-1.33 |
0.01
| 0.22 | 0.79 | 0.54-1.15 |
BDNF | rs6265 | AG | A | A | G (obesity) | 16.2 | 2.2 | 0.11 | 0.10 | 1.33 | 0.95-1.85 | 0.10 | 0.07 | 1.43 | 0.98-2.09 |
BDNF | rs925946 | GT | T | G | T (obesity) | 30.7 | 11.1 |
0.01
| 0.08 | 0.79 | 0.61-1.02 |
0.043
| 0.06 | 0.75 | 0.56-1.01 |
Table 3
Univariable and multivariable associations of obesity and diabetes SNPs with small for gestational age at term (genotype data)
rs9939609 | A | 61 | 0.91 (0.50 - 1.64) | 0.96 (0.47 - 1.94) |
FTO | AT | 265 |
1.54 (1.07 - 2.22)
| 1.30 (0.85 - 1.99) |
| T | 218 | Ref | Ref |
rs864745 | A | 145 | Ref | Ref |
JAZF1 | AG | 346 |
1.57 (1.03 - 2.39)
| 1.43 (0.88 - 2.32) |
| G | 136 | 1.18 (0.73 - 1.91) | 1.04 (0.59 - 1.83) |
rs5219 | C | 223 | Ref | Ref |
KCNJ11 | CT | 252 |
1.64 (1.13 - 2.37)
| 1.50 (0.98 - 2.31) |
| T | 76 | 1.59 (0.94 - 2.69) |
1.90 (1.04 - 3.50)
|
rs6265 | A | 17 |
2.84 (1.03 - 7.87)
|
3.29 (1.08 - 9.99)
|
BDNF | AG | 142 | 1.17 (0.79 - 1.74) | 1.18 (0.74 - 1.90) |
| G | 347 | Ref | Ref |
rs925946 | G | 232 | Ref | Ref |
BDNF | T | 66 | 0.84 (0.48 -1.46) | 0.71 (0.38 - 1.34) |
| GT | 249 |
0.58 (0.40 -0.83)
|
0.58 (0.38 - 0.89)
|
rs6602024 | A | 0 | undefined | undefined |
PFKP | GA | 116 | 0.68 (0.44 - 1.04) |
0.57 (0.35 - 0.95)
|
| G | 435 | Ref | Ref |
rs10508503 | C | 447 | Ref | Ref |
PTER | CT | 82 |
0.55 (0.33 - 0.91)
|
0.51 (0.28 - 0.91)
|
| T | 3 | 2.49 (0.22 - 27.7) | 1.19 (0.09 -16.58) |
rs10913469 | C | 13 | 2.94 (0.89 - 9.73) | 2.54 (0.65 - 9.97) |
SEC16B | TC | 367 | 0.74 (0.50 - 1.09) |
0.56 (0.35 - 0.89)
|
| T | 158 | Ref | Ref |
Six SNPs demonstrated statistical significance at p < 0.05 in either the univariable or multivariable analysis: rs9939609 which is an intronic SNP in FTO, rs5219 which is a missense (Lys-Glu) SNP in KCNJ11, rs925946 which is located 9,240 bp from BDNF, rs6602024 which is an intronic SNP in PFKP, rs10508503 which is located 179,016 bp from PTER and rs10913469 which is an intronic SNP in SEC16B.
As we have two SNPs in BDNF and these two SNPs are in LD (D' = 1, r2 = 0.116) and exist within the same haplotype block (confirmed using haploview 4.2) we conducted a haplotype analysis to determine if the haplotype would give stronger results than the individual SNPs (data not shown). The haplotype analysis of rs6265 and rs925946 found an overall effect (Global Stat = 5.92, p = 0.05). In univariable analysis compared to the GG haplotype the AG haplotype did not show a statistically increased risk (OR = 1.22, 95%CI = 0.86-1.68), whilst those with the GT haplotype had a borderline decreased risk (OR = 0.78, 95%CI = 0.59-1.04). In multivariable analyses these odds ratios moved towards unity and were not statistically significant suggesting that the haplotype analysis does not add anything further to the analysis of each SNP individually.
We have examined anthropometric characteristics of the children at 11 years of age (table
4) and found that the children born SGA remain significantly lighter, shorter and still have lower BMI than the AGA children. Hence not all of the SGA children have shown catch up growth.
Table 4
Anthropometric characteristics of children at 11 years of age.
Weight (kg)
| 40.6 (10.5) | 43.9 (10.3) | 3.85 (< 0.0001) |
Weight SDS
†
| 0.26 (1.14) | 0.71 (1.04) | 4.80 (< 0.0001) |
Height (cm)
| 147.2 (7.6) | 150.9 (7.4) | 6.06 (< 0.0001) |
Height SDS
†
| 0.16 (1.07) | 0.70 (1.04) | 5.92 (< 0.0001) |
BMI
| 18.6 (3.7) | 19.1 (3.2) | 1.98 (0.048) |
BMI SDS
††
| 0.22 (1.22) | 0.50 (1.10) | 2.91 (0.004) |
Discussion
We have found associations (with p values less than 0.05) for SGA with the diabetes related SNP in KCNJ11 and the obesity related SNPs in FTO, PFKP, PTER, SEC16B and BDNF. After controlling for potential confounders the association with the FTO SNP did not remain significant, whilst the other 5 SNPs were positively associated with SGA in the multivariable model.
The T allele of KCNJ11 SNP rs5219 is associated with type 2 diabetes in adults and has been shown to be associated with reduced insulin secretion (see table
1 for references) so our study result finding that this risk allele is associated with being SGA is compatible with the fetal insulin hypothesis where genetically mediated reduced insulin secretion beginning in-utero results in reduced birthweight, and later increases the risk of developing T2 D. Two previous studies evaluated the diabetes related
KCNJ11 variant with birthweight and found no association [
31,
32]. It is possible that this variant interacts with other factors, either genetic or environmental, that exist within the ABC cohort but are not present in the other two studies.
Our study found that the high risk allele for obesity in the PTER SNP (C allele at rs10508503) was associated with being SGA. This finding would fit with the fetal insulin hypothesis only if this allele had a direct effect on increasing insulin resistance prior to manifesting as increased BMI later in life, and thus manifests as low birth weight and later leads to obesity. Alternatively, the association of this obesity gene in SGA babies may be due to some survival advantage of being a "thin-fat" baby in terms of inappropriate fat mass for body size [
33], not discerned by the simple measure of birth weight. It may be that most of these SGA babies grow into genetically predisposed obese children and adults; hence we are observing the association with post-natal obesity in our SGA cohort.
Conversely, our study found an association of SGA with the low risk alleles for obesity in the BDNF and SEC16B genes suggesting that these alleles may confer a propensity to small size beginning in-utero, since the same SNP in BDNF has been associated with thinness in women [
34]. It would be interesting to examine whether this sub-group of SGA babies go on to have improved metabolic outcomes later in life by having a lower risk of obesity.
Since we began this study associations between common variants in type 2 diabetes susceptibility genes have been tested in several large birthweight cohorts. Freathy
et al, 2009 [
35] looked at five type 2 diabetes susceptibility genes and found that the
CDKAL1 and
HHEX-IDE loci were associated with reduced birth weight. They did not detect an association with
CDKN2A/B,
IGF2BP2, and
SLC30A8. All 5 of these loci were included in our study and we did not detect an association for any of them with SGA. Zhao
et al, 2009 [
36] also observed an association between lower birth weight and the
CDKAL1 locus. However, no association was found with 19 other diabetes genes examined, including
KCNJ11 for which we found an association with SGA. Pulizzi
et al, 2009 [
37] investigated 9 diabetes genes, all of which are included in our study but were not found to be associated with SGA. Of the tested variants, the risk variant in
HHEX showed a trend towards a low birthweight and the risk variant in the
CDKN2A/2B locus was associated with high birthweight. The three studies described above investigated birthweight. Only
TCF7L2 has been studied for association with SGA [
38,
39]. The gene was not associated with SGA in these two cohorts or our own. However, an association has been described between
TCF7L2 and birthweight, although the effect was strongest with maternal genotype and after adjustment for maternal genotype fetal
TCF7L2 genotype was not associated with birth weight [
40].
We examined the publically available British 1958 birth cohort database
http://www.b58cgene.sgul.ac.uk/ for our significant genes. SNPs in
BDNF and
FTO were associated with birthweight but
KCNJ11, PTER, PFKP and
SEC16B did not show any associations.
The failure to replicate the associations reported by Freathy et al, Pulizzi et al and Zhao et al and our reporting of significant results for different genes may be due to the different phenotype used (birthweight vs. SGA) and/or due to different study populations with different environmental and genetic influences.
To summarise, we have identified five SNPs/genes which are associated with SGA. While noting that replication in independent samples is essential, our data provides evidence that genetic variation in type 2 diabetes and obesity susceptibility genes such as KCNJ11, BDNF, PFKP, PTER and SEC16B have a possible role in SGA as well as their established roles in obesity and/or diabetes.
We recognise that the association observed with these SNPs are unlikely to survive any adjustment for multiple testing and could thus be false positives. But it is possible that we may be seeing small genetic effects here and as our sample size is small compared to the majority of genetic association studies today we have low power to detect these associations with a high level of statistical significance. Calculations of statistical power using PS 2.1.31 [
41] show that for the ABC study we have 31.61% power to detect an odds ratio of 1.2, 56.84% power to detect an odds ratio of 1.3 and 78.01% power to detect an odds ratio of 1.4 for a SNP with a minor allele frequency of 0.48 (such as rs864745 in JAZF11). For SNPs with a lower allele frequency the power would be less. For example for a SNP with a minor allele frequency of 0.12 (such as rs6602024 in PFKP) we have 17.36% power to detect an odds ratio of 1.2, 31.42% power to detect an odds ratio of 1.3 and 48.05% power to detect an odds ratio of 1.4.
It is also possible that these genes may have more subtle effects and could affect a related phenotype, rather than be directly associated with SGA. Although beyond the scope of this paper it would be interesting to look at these SNPs/genes in relation such phenotypes e.g., catch up growth. Alternatively, the associations could reflect underlying LD with other markers in these genes. Further analysis in these genes with which we demonstrate an association with SGA is therefore required. Also, further investigation of the 36 genes for which we found no association should not be ruled out. The lack of association of these genes with SGA in our sample could be explained by a lack of power and we cannot rule out that we were unable to detect smaller effects of these variants. It is also possible that these obesity and/or diabetes genes may lead to small decreases in birthweight but do not result in the more severe SGA phenotype. Alternatively, it may be possible that any direct effects of susceptibility genes resulting in an individual being born SGA (by reduced insulin secretion) may be offset by an opposing effect from the maternal genotype (through the effects of the same variants on maternal glucose levels) [
42]. Unfortunately, maternal DNA samples are not presently available from the ABC cohort and so we are unable to test this.
During revision of this manuscript Freathy and colleagues reported a meta-analysis of genome-wide association studies and followed up the top hits in 13 replication studies [
43]. They identified two loci, in
ADCY5 and near
CCNL1, that are associated with birth weight and explain 0.3% and 0.1% of the variance in birth weight, respectively. Both loci were also associated with smallness for gestational age. SNPs in
ADCY5 have recently been implicated in regulation of glucose levels and susceptibility to type 2 diabetes [
44], providing further evidence that the association between lower birth weight and/or SGA and subsequent type 2 diabetes does indeed have a genetic component.
Acknowledgements
The initial study was funded by the Health Research Council of New Zealand. The 12 month postal questionnaire was funded by Hawkes Bay Medical Research Foundation. The 3.5 year follow-up study was funded by Child Health Research Foundation, Becroft Foundation and Auckland Medical Research Foundation. The 7 year follow-up study was funded by Child Health Research Foundation. The 11 year follow-up was funded by Child Health Research foundation and the Heart Foundation. The genetic component of this study was funded by Child Health Research Foundation.
EA Mitchell and JMD Thompson are supported by the Child Health Research Foundation. The 7 year follow-up study was conducted in the Children's Research Centre which is supported in part by the Starship Foundation and the Auckland District Health Board. We acknowledge the assistance of Gail Gillies, Barbara Rotherham and Helen Nagels for contacting or assessing the participants. We sincerely thank the parents and children for participating in this study.
AR Morgan, WJ Lam and LR Ferguson are supported by Nutrigenomics New Zealand which is a collaboration between AgResearch Ltd., Plant & Food Research and The University of Auckland with funding through the Foundation for Research Science and Technology.
We acknowledge use of genotype data from the British 1958 Birth Cohort DNA collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
ARM made substantial contributions to this study. She identified genes to investigate, designed and carried out the genotyping experiments and was primary author of the manuscript. JMDT was responsible for the analysis and interpretation of data and contributed to the writing of the manuscript. He also helped in establishing the ABC cohort and its data collection. RM participated in the writing of the manuscript. PNB gave advice on study design and participated in the writing of the manuscript. WJL was responsible for DNA extraction and also assisted with the genotyping experiments. LRF participated in study design and coordination, and in editing of the manuscript. EAM conceived the study, and participated in its design and coordination. He also established the ABC cohort and its data collection. All authors read and approved the final manuscript.